TMBC Monthly Newsletter, July 2018, V18
|
|
Every month The Microbiome Coalition (TMBC) will bring you the latest in research, news and information to keep you up to date on the microbiome industry.
We welcome your feedback and suggestions for content.
Follow us on Twitter, @TMBCoalition
|
|
Exciting New TMBC Updates!
|
|
The Microbiome Coalition is Coming to Town!
TMBC will be hosting a series of informal networking events this coming fall through early 2019 to bring the microbiome communities together in San Diego, San Francisco, Boston and Washington, D.C. These events are meant to help the community connect, chat, share a beverage and hopefully learn more about what the community envisions for TMBC and the future of the microbiome.
Stay tuned for further information about dates and locations, our first event to be held in San Francisco, with an anticipated September date.
If you are interested in sponsoring an event in one of these cities, or your city if is not listed and you'd like us to visit, please get in touch at
info@themicrobiomecoalition.com
|
|
Series A Round Could Bring French Microbiome Treatment for Bowel Disease Into the Clinic
Netbiotix has raised €7.5M to bring its lead candidate for inflammatory bowel disease into clinical trials. The Series A round was led by Auriga Partners, who were joined by other investors, including Biocodex, a multinational pharmaceutical company focused on gastroenterology and microbiome research. The treatment uses
Faecalibacterium prausnitzii
in the gut to prevent and dampen inflammation. Full article
here
Jennewein Biotechnologie to Build New R&D Centre for Synthetic Organisms and Microbiome Research in Bonn, Germany
Jennewein Biotechnologie is building a new R&D Center for Microbiome Research and Synthetic Designer Microorganisms. 3.6-million euros will be invested at the location in Bonn for a new laboratory equipment. Research activities will be in the area of metabolic engineering specialized in designer microorganisms and the exploration of the human microbiome. Full press release
here
Diversigen and Norgen Biotek Partner to Offer End-to-end Solutions for Microbiome Sample and Analysis Research
The two companies announced that they have entered into a strategic partnership through which industry and academic researchers will benefit from comprehensive end-to-end logistical, sequencing, and analytical solutions to meet the growing needs for microbiome analyses. Full press release
here
Bifido wins patent for microbiome-based treatment in US
Bifido is the first Korean company to win a patent for a microbiome-using treatment in the U.S. The company has been developing a therapy for rheumatoid arthritis (RA) using the intestinal microbiome, jointly with Catholic University Seoul St. Mary’s Hospital since 2017. Based on the joint study, the company obtained a local patent for “Pharmabiotics composition targeting rheumatoid arthritis using bifidobacterium” in January. Full article
here
|
|
Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women
Hepatic steatosis is a condition that is often observed in obese patients and is a prelude to non-alcoholic fatty liver disease. We reveal molecular networks linking the gut microbiome and the host phenome to hepatic steatosis. Patients with steatosis have low microbial gene richness and increased genetic potential for the processing of dietary lipids and endotoxin biosynthesis, hepatic inflammation and dysregulation of aromatic and branched-chain amino acid metabolism. Full article
here
Vaginal microbiome may influence stress levels of offspring
Exposing newborn mice to vaginal microbes from stressed female mice may transfer the effects of stress to the newborns, according to a new study. These changes resemble those seen specifically in the male offspring of moms that were stressed during pregnancy. Full article
here
A single genetic change in gut bacteria alters host metabolism
Scientists have found that deleting a single gene in a particular strain of gut bacteria causes changes in metabolism and reduced weight gain in mice, according to a study in the journal
eLife
. Full article, "A selective gut bacterial bile salt hydrolase alters host metabolism,"
here
|
|
Scientists To Search for Bacteria on Famed World Monuments
To better understand this mysterious hidden world, scientists will be collecting bacteria from monuments at Gettysburg Battlefield and Fort McHenry in Baltimore. This work is part of the Monumentome project, which will collect samples from the world’s greatest monuments. The goal: to provide the first catalog of microorganisms on monuments around the world, information that can be used by authorities in conserving the monuments. Full article
here
|
|
Bioinformatics Cloud Engineer, Second Genome
They’re on the search for a computer scientist, computational biologist, or software engineer with a passion for platform development. The individual will develop Second Genome’s genomic and metagenomic data management and discovery cloud platform using software development lifecycle principles; actively seek, evaluate, scale, and spearhead the adoption of new computational approaches to expand our data science capabilities; and communicate findings within the group and to stakeholders inside and outside the company. Learn more
here
Manufacturing Research Associate, Whole Biome
They seek a Research Associate to join Whole Biome’s Manufacturing Team. This person will be responsible for working with a team of microbiologists to culture, harvest and encapsulate Whole Biome’s proprietary medical food products. Additionally, this person will have the opportunity to work with the Molecular Biology, Compute and Medical Teams to support and enable the discovery and development of novel, life-changing microbiome interventions. Learn more
here
Inside Sales Representative, CosmosID
CosmosID is recruiting an Inside Sales Representative to support their sales, marketing, and overall growth of the business. This position is for someone who is driven, organized, embraces change, and is very willing to learn in a field that is constantly evolving. Learn more
here
|
|
Accelerating Human Microbiome Therapies From Discovery to Commercial Success
This conference brings you the latest scientific data, regulatory insights, and funding solutions. They have 3 focus areas: science, technology, and clinical development; manufacturing, production, and commercialization; and regulating and funding the growing microbiome therapeutics market. Boston, MA. September 5-6.
https://lifesciences.knect365.com/microbiome-therapeutics-us/
BioTech Pharma Summit: Gut-Brain Axis 2018
This year’s event brings together leading scientists, physicians, and senior leaders to explore the brain and its engagement with the GI-nervous system axis in health and disease. The ability of gut microbiota to communicate with the brain is emerging as an exciting concept in health and disease. Paris, France. September 6-7.
https://biotechpharmasummit.com/index.php/event/gut-brain-axis-2018/
Skin Microbiome Congress
Join 200+ industry experts from multinational pharmaceutical, beauty and personal care companies, along with the independent skincare brands and innovative biotechs who are advancing the field. Discover the potential of prebiotic, probiotic and postbiotic products being developed to protect and promote a healthy microbiome and ultimately combat dermatological conditions from acne and eczema to dandruff and skin allergies. San Francisco, CA. September 12-13.
https://www.skinmicrobiomecongressca.com/events/skin-microbiome-westcoast-2018
Connecticut Microbiome Initiative: Microbiome Innovation & Investment Summit
Held at JAX Genomic Medicine on the UCONN Health campus, this conference will bring together a wide variety of people interested in microbiome research, scientific collaborations, and new company formation in this arena. The Summit is being organized as part of a new initiative to link microbiome research strengths at Yale, UConn, and JAX with business development activities in the state of Connecticut. Farmington, CT. September 19.
https://ctmicrobiome.com/events/microbiome-innovation-investment-summit/
|
|
Consider joining the coalition. Members of TMBC participate on our committees, attend our events, generate networking and business development opportunities and, most importantly, contribute to the growth and success of a unique organization that is positioned to ensure that public opinion and policy pave the way for microbiome based therapeutics, diagnostics and direct-to-consumer services and products.
Membership Categories
• Sole proprietor (legal, consulting, other) • Academic and clinical institutions
• Patient advocacy groups • Industry/trade associations
• Corporations (pharmaceutical, diagnostic,bioinformatics, other)
Benefits of Membership
• Shape the Future of Microbiome Policy • Curated research library
• Monthly newsletter • White papers • Extended network • Job listings • Event listings
See our
flyer
for more details
|
|
Promoting Greater Understanding of the Role
of the Microbiome in Human Health and Wellness
|
|
|
|
|
|
|
